Villin-1
Showing 1 - 25 of >10,000
The Detrimental Course of Acute Intestinal Ischemia
Recruiting
- Diagnoses Disease
- +2 more
- Biomarker validation and VOC profile identification
-
Leuven, Vlaams-Brabant, Belgium
- +5 more
Jan 4, 2022
Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma, Duodenal Carcinoma Trial in Puerto Rico, United States
Recruiting
- Attenuated Familial Adenomatous Polyposis
- +3 more
- Biopsy
- +2 more
-
Scottsdale, Arizona
- +5 more
Dec 30, 2022
Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma, Duodenal Carcinoma Trial in Puerto Rico, United States
Not yet recruiting
- Familial Adenomatous Polyposis
- Obeticholic Acid
- Placebo
-
Phoenix, Arizona
- +4 more
Nov 18, 2021
Esophageal Adenocarcinoma, Barrett Esophagus, Colorectal Adenoma Trial in Groningen (SENSITIVE system)
Not yet recruiting
- Esophageal Adenocarcinoma
- +6 more
- SENSITIVE system
-
Groningen, NetherlandsUniversity Medical Center Groningen
Feb 9, 2022
Human Intestinal Amino Acid Absorption and Role ofLocal RAS
Completed
- Renin-Angiotensin Aldosterone System (RAS)
- biopsy of intestinal tissue
- +2 more
-
Basel, Switzerland
- +1 more
Aug 19, 2020
Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )
Completed
- Rheumatoid Arthritis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
COVID-19 Trial in Thái Bình (COVIVAC vaccine)
Completed
- COVID-19
- COVIVAC vaccine
-
Thái Bình, Thai Binh, VietnamDistrict Health Center of Vu Thu District
Jul 12, 2023
Ankylosing Spondylitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, Placebo)
Completed
- Ankylosing Spondylitis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 10, 2023
Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)
Not yet recruiting
- Relapsing Remitting Multiple Sclerosis
- PIPE-307 Dose A
- +2 more
- (no location specified)
Oct 9, 2023
Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of
Not yet recruiting
- Meningococcal Meningitis
- batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
- +3 more
-
Surabaya, IndonesiaHusada Utama Hospital
Nov 13, 2023
Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)
Not yet recruiting
- Hepatocellular Carcinoma
- iNKT Cells
- +2 more
-
Beijing, Beijing, ChinaBeijing Youan Hospital,Capital Medical University
Jul 24, 2023
Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )
Completed
- Atopic Dermatitis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaJianzhong Zhang
Oct 10, 2023
Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)
Not yet recruiting
- Hypertension,Essential
- Songling Xuemaikang Capsules
- +2 more
-
Beijing, Beijing, China
- +4 more
Oct 17, 2023
Diabetes Trial (INS062 injection?INS068 injection?HR20014 injection)
Not yet recruiting
- Diabetes
- INS062 injection、INS068 injection、HR20014 injection
- (no location specified)
May 24, 2023
Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)
Recruiting
- Lymphoblastic Lymphoma
- +2 more
- BEAM-201
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 2, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 22, 2023
Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )
Recruiting
- Type1diabetes
- +2 more
- Infusion of GIP[1-42], GIP[1-30] or placebo
-
Hellerup, Copenhagen, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 13, 2023
Serum Retinoic Acid Induced Protein 14 and Metastasis Associated
Not yet recruiting
- Breast Cancer
- laboratory test (RAI14 and MACC-1 )
- (no location specified)
Oct 18, 2023
Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)
Recruiting
- Pulmonary Tuberculosis
- Other Specified Pulmonary Tuberculosis
- Sutezolid
- +6 more
-
Lambaréné, Gabon
- +7 more
Apr 17, 2023
Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)
Not yet recruiting
- Healthy Women of Child Bearing Potential
- R21/Matrix-M1
- +2 more
- (no location specified)
Oct 10, 2023
HIV Prevention Trial in Worldwide (Placebo rectal insert, Placebo rectal suppository, Placebo rectal douche)
Completed
- HIV Prevention
- Placebo rectal insert
- +2 more
-
Birmingham, Alabama
- +6 more
Jan 4, 2023
Tetanus Trial in Bijie (TTVA, TT)
Not yet recruiting
- Tetanus
- TTVA
- TT
-
Bijie, Guizhou, ChinaCenter for Disease Control and Prevention, Qixingguan District,
Nov 7, 2023
Tetanus Trial in Bijie (TTVA, TT)
Not yet recruiting
- Tetanus
- TTVA
- TT
-
Bijie, Guizhou, ChinaCenter for Disease Control and Prevention, Qixingguan District,
Nov 7, 2023